Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

BIOMARIN PHARMACEUTICAL INC (BMRN)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21Mar-31-21Dec-31-20
   8-K10-Q10-Q10-K10-Q10-Q10-Q10-K
REVENUES:          
Total revenues   1,911.71,879.61,846.31,848.61,916.61,844.41,860.5
            Total revenues growth   -0.3%1.9%-0.8%-0.8%3.8%2.2%9.2%
OPERATING EXPENSES:          
Cost of sales   463.4467.3470.5476.9562.2533.1524.3
Research and development   638.0640.9628.8624.4613.6634.6628.1
Selling, general and administrative   792.4779.7759.4737.3733.4724.7737.7
Intangible asset amortization and contingent consideration   68.669.869.971.371.568.766.7
Gain on sale of nonfinancial assets, net    -108.0    -52.8
    Total operating expenses   1,854.31,849.71,928.61,916.61,987.31,967.71,903.9
    INCOME (LOSS) FROM OPERATIONS   57.429.9-82.3-68.0-70.7-123.3-43.4
            Operating margin   3.0%1.6%-4.5%-3.7%-3.7%-6.7%-2.3%
Interest income   7.99.910.511.814.013.816.6
Interest expense   -15.4-15.3-15.3-16.2-22.0-26.2-29.3
Other income (expense), net   4.99.710.315.57.88.57.1
    INCOME (LOSS) BEFORE INCOME TAXES   56.335.6-75.4-55.6-70.7-127.1-49.0
Provision for (benefit from) income taxes   2.2-3.7-11.3-66.5-902.8-917.1-903.0
    NET INCOME (LOSS)   54.139.3-64.110.8832.1790.0854.0
   
EARNINGS (LOSS) PER SHARE, BASIC (in dollars per share)   $0.29$0.21($0.35)$0.06$4.59$4.36$4.71
EARNINGS (LOSS) PER SHARE, DILUTED (in dollars per share)   $0.26$0.18($0.36)$0.07$4.28$4.05$4.40
   
Weighted-average common shares outstanding, basic (in shares)   183.8183.2182.7182.2181.6181.1180.6
Weighted average common shares outstanding, diluted (in shares)   187.1186.6184.0186.2189.8188.6189.3

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy